Copyright Reports & Markets. All rights reserved.

Global Cardiac Biomarkers Market Research Report 2019

Request for Sample of this report
Buy now

1 Report Overview

  • 1.1 Study Scope
  • 1.2 Key Market Segments
  • 1.3 Players Covered: Ranking by Cardiac Biomarkers Revenue
  • 1.4 Market by Type
    • 1.4.1 Global Cardiac Biomarkers Market Size Growth Rate by Type: 2020 VS 2026
    • 1.4.2 Troponin
    • 1.4.3 CK-MB
    • 1.4.4 Natriuretic Peptides - BNP and NT-proBNP
    • 1.4.5 Myoglobin
    • 1.4.6 Others
  • 1.5 Market by Application
    • 1.5.1 Global Cardiac Biomarkers Market Share by Application: 2020 VS 2026
    • 1.5.2 Acute Coronary Syndrome
    • 1.5.3 Myocardial Infarction
    • 1.5.4 Congestive Heart Failure
    • 1.5.5 Others
  • 1.6 Study Objectives
  • 1.7 Years Considered

2 Global Growth Trends

  • 2.1 Global Cardiac Biomarkers Market Perspective (2015-2026)
  • 2.2 Global Cardiac Biomarkers Growth Trends by Regions
    • 2.2.1 Cardiac Biomarkers Market Size by Regions: 2015 VS 2020 VS 2026
    • 2.2.2 Cardiac Biomarkers Historic Market Share by Regions (2015-2020)
    • 2.2.3 Cardiac Biomarkers Forecasted Market Size by Regions (2021-2026)
  • 2.3 Industry Trends and Growth Strategy
    • 2.3.1 Market Top Trends
    • 2.3.2 Market Drivers
    • 2.3.3 Market Challenges
    • 2.3.4 Porter’s Five Forces Analysis
    • 2.3.5 Cardiac Biomarkers Market Growth Strategy
    • 2.3.6 Primary Interviews with Key Cardiac Biomarkers Players (Opinion Leaders)

3 Competition Landscape by Key Players

  • 3.1 Global Top Cardiac Biomarkers Players by Market Size
    • 3.1.1 Global Top Cardiac Biomarkers Players by Revenue (2015-2020)
    • 3.1.2 Global Cardiac Biomarkers Revenue Market Share by Players (2015-2020)
    • 3.1.3 Global Cardiac Biomarkers Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
  • 3.2 Global Cardiac Biomarkers Market Concentration Ratio
    • 3.2.1 Global Cardiac Biomarkers Market Concentration Ratio (CR5 and HHI)
    • 3.2.2 Global Top 10 and Top 5 Companies by Cardiac Biomarkers Revenue in 2019
  • 3.3 Cardiac Biomarkers Key Players Head office and Area Served
  • 3.4 Key Players Cardiac Biomarkers Product Solution and Service
  • 3.5 Date of Enter into Cardiac Biomarkers Market
  • 3.6 Mergers & Acquisitions, Expansion Plans

4 Market Size by Type (2015-2026)

  • 4.1 Global Cardiac Biomarkers Historic Market Size by Type (2015-2020)
  • 4.2 Global Cardiac Biomarkers Forecasted Market Size by Type (2021-2026)

5 Market Size by Application (2015-2026)

  • 5.1 Global Cardiac Biomarkers Market Size by Application (2015-2020)
  • 5.2 Global Cardiac Biomarkers Forecasted Market Size by Application (2021-2026)

6 North America

  • 6.1 North America Cardiac Biomarkers Market Size (2015-2020)
  • 6.2 Cardiac Biomarkers Key Players in North America (2019-2020)
  • 6.3 North America Cardiac Biomarkers Market Size by Type (2015-2020)
  • 6.4 North America Cardiac Biomarkers Market Size by Application (2015-2020)

7 Europe

  • 7.1 Europe Cardiac Biomarkers Market Size (2015-2020)
  • 7.2 Cardiac Biomarkers Key Players in Europe (2019-2020)
  • 7.3 Europe Cardiac Biomarkers Market Size by Type (2015-2020)
  • 7.4 Europe Cardiac Biomarkers Market Size by Application (2015-2020)

8 China

  • 8.1 China Cardiac Biomarkers Market Size (2015-2020)
  • 8.2 Cardiac Biomarkers Key Players in China (2019-2020)
  • 8.3 China Cardiac Biomarkers Market Size by Type (2015-2020)
  • 8.4 China Cardiac Biomarkers Market Size by Application (2015-2020)

9 Japan

  • 9.1 Japan Cardiac Biomarkers Market Size (2015-2020)
  • 9.2 Cardiac Biomarkers Key Players in Japan (2019-2020)
  • 9.3 Japan Cardiac Biomarkers Market Size by Type (2015-2020)
  • 9.4 Japan Cardiac Biomarkers Market Size by Application (2015-2020)

10 Southeast Asia

  • 10.1 Southeast Asia Cardiac Biomarkers Market Size (2015-2020)
  • 10.2 Cardiac Biomarkers Key Players in Southeast Asia (2019-2020)
  • 10.3 Southeast Asia Cardiac Biomarkers Market Size by Type (2015-2020)
  • 10.4 Southeast Asia Cardiac Biomarkers Market Size by Application (2015-2020)

11 India

  • 11.1 India Cardiac Biomarkers Market Size (2015-2020)
  • 11.2 Cardiac Biomarkers Key Players in India (2019-2020)
  • 11.3 India Cardiac Biomarkers Market Size by Type (2015-2020)
  • 11.4 India Cardiac Biomarkers Market Size by Application (2015-2020)

12 Central & South America

  • 12.1 Central & South America Cardiac Biomarkers Market Size (2015-2020)
  • 12.2 Cardiac Biomarkers Key Players in Central & South America (2019-2020)
  • 12.3 Central & South America Cardiac Biomarkers Market Size by Type (2015-2020)
  • 12.4 Central & South America Cardiac Biomarkers Market Size by Application (2015-2020)

13 Key Players Profiles

  • 13.1 Abbott
    • 13.1.1 Abbott Company Details
    • 13.1.2 Abbott Business Overview
    • 13.1.3 Abbott Cardiac Biomarkers Introduction
    • 13.1.4 Abbott Revenue in Cardiac Biomarkers Business (2015-2020))
    • 13.1.5 Abbott Recent Development
  • 13.2 Abbott
    • 13.2.1 Abbott Company Details
    • 13.2.2 Abbott Business Overview
    • 13.2.3 Abbott Cardiac Biomarkers Introduction
    • 13.2.4 Abbott Revenue in Cardiac Biomarkers Business (2015-2020)
    • 13.2.5 Abbott Recent Development
  • 13.3 F. Hoffmann-La Roche
    • 13.3.1 F. Hoffmann-La Roche Company Details
    • 13.3.2 F. Hoffmann-La Roche Business Overview
    • 13.3.3 F. Hoffmann-La Roche Cardiac Biomarkers Introduction
    • 13.3.4 F. Hoffmann-La Roche Revenue in Cardiac Biomarkers Business (2015-2020)
    • 13.3.5 F. Hoffmann-La Roche Recent Development
  • 13.4 Advanced ImmunoChemical
    • 13.4.1 Advanced ImmunoChemical Company Details
    • 13.4.2 Advanced ImmunoChemical Business Overview
    • 13.4.3 Advanced ImmunoChemical Cardiac Biomarkers Introduction
    • 13.4.4 Advanced ImmunoChemical Revenue in Cardiac Biomarkers Business (2015-2020)
    • 13.4.5 Advanced ImmunoChemical Recent Development
  • 13.5 AgPlus Diagnostics
    • 13.5.1 AgPlus Diagnostics Company Details
    • 13.5.2 AgPlus Diagnostics Business Overview
    • 13.5.3 AgPlus Diagnostics Cardiac Biomarkers Introduction
    • 13.5.4 AgPlus Diagnostics Revenue in Cardiac Biomarkers Business (2015-2020)
    • 13.5.5 AgPlus Diagnostics Recent Development
  • 13.6 BG Medicine
    • 13.6.1 BG Medicine Company Details
    • 13.6.2 BG Medicine Business Overview
    • 13.6.3 BG Medicine Cardiac Biomarkers Introduction
    • 13.6.4 BG Medicine Revenue in Cardiac Biomarkers Business (2015-2020)
    • 13.6.5 BG Medicine Recent Development
  • 13.7 BioLegend
    • 13.7.1 BioLegend Company Details
    • 13.7.2 BioLegend Business Overview
    • 13.7.3 BioLegend Cardiac Biomarkers Introduction
    • 13.7.4 BioLegend Revenue in Cardiac Biomarkers Business (2015-2020)
    • 13.7.5 BioLegend Recent Development
  • 13.8 bioMérieux
    • 13.8.1 bioMérieux Company Details
    • 13.8.2 bioMérieux Business Overview
    • 13.8.3 bioMérieux Cardiac Biomarkers Introduction
    • 13.8.4 bioMérieux Revenue in Cardiac Biomarkers Business (2015-2020)
    • 13.8.5 bioMérieux Recent Development
  • 13.9 Bio-Rad Laboratories
    • 13.9.1 Bio-Rad Laboratories Company Details
    • 13.9.2 Bio-Rad Laboratories Business Overview
    • 13.9.3 Bio-Rad Laboratories Cardiac Biomarkers Introduction
    • 13.9.4 Bio-Rad Laboratories Revenue in Cardiac Biomarkers Business (2015-2020)
    • 13.9.5 Bio-Rad Laboratories Recent Development
  • 13.10 BODITECH MED
    • 13.10.1 BODITECH MED Company Details
    • 13.10.2 BODITECH MED Business Overview
    • 13.10.3 BODITECH MED Cardiac Biomarkers Introduction
    • 13.10.4 BODITECH MED Revenue in Cardiac Biomarkers Business (2015-2020)
    • 13.10.5 BODITECH MED Recent Development

14 Analyst's Viewpoints/Conclusions

    15 Appendix

    • 15.1 Research Methodology
      • 15.1.1 Methodology/Research Approach
      • 15.1.2 Data Source
    • 15.2 Disclaimer

    Cardiac Biomarkers market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Cardiac Biomarkers market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2015-2026.

    The key players covered in this study
    Abbott
    Abbott
    F. Hoffmann-La Roche
    Advanced ImmunoChemical
    AgPlus Diagnostics
    BG Medicine
    BioLegend
    bioMérieux
    Bio-Rad Laboratories
    BODITECH MED

    Market segment by Type, the product can be split into
    Troponin
    CK-MB
    Natriuretic Peptides - BNP and NT-proBNP
    Myoglobin
    Others
    Market segment by Application, split into
    Acute Coronary Syndrome
    Myocardial Infarction
    Congestive Heart Failure
    Others

    Market segment by Regions/Countries, this report covers
    North America
    Europe
    China
    Japan
    Southeast Asia
    India
    Central & South America

    Buy now